146 related articles for article (PubMed ID: 9362425)
1. Mechanisms of the development of osteoblastic metastases.
Goltzman D
Cancer; 1997 Oct; 80(8 Suppl):1581-7. PubMed ID: 9362425
[TBL] [Abstract][Full Text] [Related]
2. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
[TBL] [Abstract][Full Text] [Related]
3. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells.
Rabbani SA; Desjardins J; Bell AW; Banville D; Mazar A; Henkin J; Goltzman D
Biochem Biophys Res Commun; 1990 Dec; 173(3):1058-64. PubMed ID: 2125213
[TBL] [Abstract][Full Text] [Related]
4. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
[TBL] [Abstract][Full Text] [Related]
5. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
Koutsilieris M; Frenette G; Lazure C; Lehoux JG; Govindan MV; Polychronakos C
Anticancer Res; 1993; 13(2):481-6. PubMed ID: 7685989
[TBL] [Abstract][Full Text] [Related]
7. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
[TBL] [Abstract][Full Text] [Related]
8. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment.
Koeneman KS; Yeung F; Chung LW
Prostate; 1999 Jun; 39(4):246-61. PubMed ID: 10344214
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
10. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
Rabbani SA; Mazar AP; Bernier SM; Haq M; Bolivar I; Henkin J; Goltzman D
J Biol Chem; 1992 Jul; 267(20):14151-6. PubMed ID: 1321137
[TBL] [Abstract][Full Text] [Related]
12. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
13. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
Achbarou A; Kaiser S; Tremblay G; Ste-Marie LG; Brodt P; Goltzman D; Rabbani SA
Cancer Res; 1994 May; 54(9):2372-7. PubMed ID: 8162583
[TBL] [Abstract][Full Text] [Related]
14. Tumor-bone cellular interactions in skeletal metastases.
Chirgwin JM; Mohammad KS; Guise TA
J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):308-18. PubMed ID: 15615499
[TBL] [Abstract][Full Text] [Related]
15. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo.
Rabbani SA; Gladu J; Harakidas P; Jamison B; Goltzman D
Int J Cancer; 1999 Jan; 80(2):257-64. PubMed ID: 9935208
[TBL] [Abstract][Full Text] [Related]
16. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies.
Rabbani SA; Xing RH
Int J Oncol; 1998 Apr; 12(4):911-20. PubMed ID: 9499455
[TBL] [Abstract][Full Text] [Related]
17. Role of Wnts in prostate cancer bone metastases.
Hall CL; Kang S; MacDougald OA; Keller ET
J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163
[TBL] [Abstract][Full Text] [Related]
18. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
[TBL] [Abstract][Full Text] [Related]
19. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
[TBL] [Abstract][Full Text] [Related]
20. Bone metastases: molecular mechanisms and novel therapeutic interventions.
Papachristou DJ; Basdra EK; Papavassiliou AG
Med Res Rev; 2012 May; 32(3):611-36. PubMed ID: 20818675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
